Vera Therapeutics, Inc. VERA 深 滬
等待開盤 12-17 09:30:00 美东时间
48.30
-0.910
-1.85%
華盛通- 最 高49.77
- 今 開49.63
- 成交量 180.76万股
- 最 低 47.88
- 昨 收 49.21
- 總市值 30.83亿
- 52周最高 51.1899
- 市盈率 靜 --
- 換手率 2.83%
- 52周最低 18.53
- 委 比 74.67%
- 總股本 6382.37万
- 歷史最高 51.61
- 量 比 0.91
- 振 幅 3.84%
- 歷史最低 5.20
- 每 手 1
- 風險率 6.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
Vera Therapeutics announces $200M public offering
Vera Therapeutics (NVSDAQ:ERA) stated on Monday that it had commenced a public offering to issue and sell $200M of shares, and the underwriters will have a 30-day option to purchase up to an additiona...
12-09 05:31
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
Vera Therapeutics, a late-stage biotech company developing treatments for serious immunologic diseases, announced plans to commence a $200 million public offering of its Class A common stock. The offering includes a 15% over-allotment option for underwriters and is being managed by J.P. Morgan, Goldman Sachs, Evercore ISI, and Cantor. Vera's lead product, atacicept, targets autoimmune diseases by blocking BAFF and APRIL. The offering will be made...
12-08 21:01
美股大行评级 | 高盛上调梅西百货目标价至22美元！ 摩根大通上调美国铝业公司目标价至45美元
今日重点评级关注：Stifel：维持X4 Pharmaceuticals"买入"评级，目标价从7.5美元升至10美元；花旗：维持UP Fintech Holding"买入"评级，目标价从17.4美元升至17.5美元
12-08 08:34
美股周涨跌榜 | Capricor周涨402.6%，核心药物取得关键性临床试验进展；DBRG周涨45.4%，曝软银有意收购
Capricor周涨402.6%，核心药物取得关键性临床试验进展；DBRG周涨45.4%，曝软银有意收购；UiPath本周上涨34.7%，财报表现强劲>>
12-06 10:17
TD Cowen Maintains Buy on Vera Therapeutics, Raises Price Target to $73
TD Cowen analyst Ritu Baral maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target from $60 to $73.
12-06 01:11
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics announced that its Compensation Committee granted inducement awards, including stock options and restricted stock units, to seven new employees under the 2024 Inducement Plan. The awards consist of non-qualified stock options for 42,000 shares and RSUs for 21,000 shares, with options and RSUs vesting over four years. The exercise price for stock options is $37.25, matching Vera's closing price on December 2, 2025. Vera Therapeut...
12-05 21:05
美股牛股 | 绩优股MongoDB大涨超22%，公司上调全年营收预测；Eventbrite飙升78.6%
绩优股MongoDB大涨超22%，公司上调全年营收预测；Eventbrite飙升78.6%，拟被5亿美元收购并私有化>>
12-03 15:05
Nutanix Posts Downbeat Q1 Results, Joins HP, Ambarella, Pagerduty And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining ar...
11-26 21:18
